AlloRx Stem Cell therapy

About Vitro Biopharma

Vitro Biopharma is a US-based biotech developing allogeneic cell therapies derived from umbilical cord Wharton's jelly. Its core technology involves a proprietary culture media (MSC-Gro) and a cGMP/ISO-certified manufacturing process designed for scalability and cost advantage. The company is led by a team with expertise in finance, science, and regulatory affairs, and is primarily focused on advancing its lead program through clinical development for autoimmune and inflammatory conditions.

Therapeutic Areas